Healing Touch and Health-Related Quality of Life in Women With Breast Cancer Receiving Radiation Therapy
2 other identifiers
interventional
40
1 country
1
Brief Summary
The purpose of this study is to evaluate the effectiveness of Healing Touch to improve health-related quality of life in women with breast cancer receiving radiation therapy. Research Hypothesis Healing Touch significantly improves health-related quality of life when compared to a placebo treatment, among women receiving radiation therapy for treatment of breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jan 2008
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 25, 2008
CompletedFirst Posted
Study publicly available on registry
February 11, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2008
CompletedJanuary 21, 2009
January 1, 2008
11 months
January 25, 2008
January 20, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure is the difference in the FACT-B total score from baseline, midpoint and end of study participation.
Measurement at study entrance, after 3 weeks and study exit (4, 5 or 6 weeks).
Secondary Outcomes (1)
Secondary endpoints are the sub-scales of the FACT-B scores physical well- being, social/family well-being, emotional well-being, functional well-being,and breast cancer subscales)
study entrance, after 3 weeks and at study exit
Study Arms (2)
1
EXPERIMENTALnon-contact Healing Touch treatment for 20-30 minutes once a week during the course of radiation therapy
2
SHAM COMPARATORA RN graduate assistant will provide a sham treatment of 20-30 minutes of presence.
Interventions
The sham/placebo treatment will consist of the RN graduate assistant standing near the table, slowly walking around from each side and to the foot of the table stopping periodically. The RN graduate assistant will be instructed to not focus on the patient in thought. While providing the placebo treatment the RN graduate assistant will mentally do multiplication equations. This serves as a distracter to keep the RN graduate assistant from setting intention or thoughts on the participant. At no time will the RN performing the placebo treatment move hands or arms over or around the participant or come in physical contact with the participant. The placebo treatment will be a minimum of 20 minutes but no greater than 30 minutes in length. A timer will be set in the treatment room to notify the practitioner of the time limit.
Behavioral: Healing Touch The Healing Touch intervention will consist of a brief meditative state in which the practitioners sets the intention of healing for the session. A hand scan to assess the biofield; consists of a technique of where the practitioner slowly moves her hands three to six inches above the body going from head to toe, to assess for any disturbances in the biofield; a non-contact Healing Touch treatment which will follow, to include a connection of the chakras. The chakras are connected by placing the hands above the body over each chakra, starting at the feet and progressing to the head. This will be followed by smoothing the biofield, achieved by the Practitioner slowly moving her hands above the body from the head and moving towards the feet (Hover-Kramer et al., 1996). At no time will the Practitioner make physical contact with the participant during the treatment. The treatment will be 20 minutes to 30 minutes in length.
Eligibility Criteria
You may qualify if:
- Any female patient being treated with radiation therapy for a diagnosis of stage 0, I, or II breast cancer
- Aged 18 years or greater
- Understands written and spoken English
- receiving 4, 5 or 6 weeks of radiation are eligible with a minimum study enrollment time of 4 weeks.
You may not qualify if:
- Anyone not meeting the above
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa L Schnepper, MSN, PhD (c)
University of Wisconsin, Milwaukee
- STUDY CHAIR
Laura M Anderko, PhD
University of Wisconsin, Milwaukee
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 25, 2008
First Posted
February 11, 2008
Study Start
January 1, 2008
Primary Completion
December 1, 2008
Study Completion
December 1, 2008
Last Updated
January 21, 2009
Record last verified: 2008-01